Spectur featured on ******'s The Call yesterday.
Any publicity is usually good publicity for a microcap, but it was a train wreck...
Scott Phillips tore Spectur to pieces, noting "an unbroken record of losses" with "EBITDA continuing to get worse... for the last four straight years." He was especially scathing of the dilution, highlighting a "4.5 times increase in the share count" since 2018. He said the company "doesn't really belong on the ASX", "doesn't seem like a particularly great [stock]" and he could find "nothing to recommend."
Joshua Barker agreed and said, that while the product has promise, "whether it's viable as a business is another question."
This is posted as a wake up call to shareholders.
We have is a product with great potential, but a woefully out-of-depth management team. We can't wait any longer. Our MD seems like a nice guy, but he has no experience in running a profitable business. It's been four years and he has failed. We need to collectively apply pressure on the board to find a serious replacement - as soon as possible.
Add to My Watchlist
What is My Watchlist?
